Standard Glass Lining Technology Ltd
Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India.[1]
- Market Cap ₹ 3,251 Cr.
- Current Price ₹ 163
- High / Low ₹ 214 / 124
- Stock P/E 84.4
- Book Value ₹ 29.9
- Dividend Yield 0.00 %
- ROCE 8.54 %
- ROE 6.16 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 46.8% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.68% over last 3 years.
- Earnings include an other income of Rs.23.9 Cr.
- Debtor days have increased from 86.1 to 106 days.
- Working capital days have increased from 253 days to 423 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|
90 | 127 | 153 | 210 | 209 | 196 | 223 | |
84 | 112 | 126 | 178 | 173 | 166 | 186 | |
Operating Profit | 6 | 15 | 27 | 32 | 37 | 30 | 37 |
OPM % | 7% | 12% | 18% | 15% | 17% | 15% | 17% |
0 | 0 | 1 | 4 | 8 | 18 | 24 | |
Interest | 0 | 1 | 3 | 4 | 5 | 6 | 6 |
Depreciation | 1 | 2 | 4 | 4 | 5 | 5 | 5 |
Profit before tax | 5 | 13 | 21 | 27 | 34 | 37 | 50 |
Tax % | 19% | 22% | 25% | 26% | 23% | 23% | |
4 | 10 | 16 | 20 | 26 | 29 | 39 | |
EPS in Rs | 4.67 | 11.06 | 10.43 | 12.75 | 14.52 | 1.44 | 2.00 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 9% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 47% |
3 Years: | 22% |
TTM: | 9% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 10% |
Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 15 | 16 | 18 | 199 |
Reserves | 4 | 14 | 45 | 98 | 316 | 396 |
3 | 18 | 23 | 25 | 50 | 35 | |
17 | 41 | 87 | 69 | 61 | 49 | |
Total Liabilities | 33 | 82 | 171 | 208 | 445 | 679 |
12 | 24 | 39 | 36 | 40 | 55 | |
CWIP | 0 | 0 | 0 | 2 | 3 | 7 |
Investments | 0 | 0 | 10 | 11 | 49 | 63 |
21 | 58 | 122 | 159 | 353 | 555 | |
Total Assets | 33 | 82 | 171 | 208 | 445 | 679 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
14 | -1 | 1 | 2 | -12 | 7 | |
-5 | -13 | -41 | -26 | -190 | -223 | |
-9 | 14 | 40 | 29 | 212 | 200 | |
Net Cash Flow | -0 | -0 | 0 | 5 | 10 | -15 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 17 | 62 | 70 | 59 | 93 | 106 |
Inventory Days | 78 | 116 | 326 | 242 | 275 | 326 |
Days Payable | 90 | 107 | 168 | 129 | 129 | 107 |
Cash Conversion Cycle | 6 | 70 | 227 | 173 | 239 | 325 |
Working Capital Days | 20 | 14 | 35 | 83 | 252 | 423 |
ROCE % | 47% | 39% | 28% | 15% | 9% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 Aug - Earnings call transcript on the financial results for Q1 FY26
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
5 Aug - Corrigendum issued to include digital signature on Q1 FY2026 Monitoring Agency Report.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 5 Aug
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
5 Aug - Earnings call recording for Q1 FY26 made available via web link.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
4 Aug - Q1 FY2026 Monitoring Agency Report confirms IPO proceeds used as per objects, no deviations noted.
Concalls
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT REC
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT
Business Overview[1] Standard Glass is among the top 5 specialized engineering equipment manufacturers for pharmaceutical and chemical sectors in India (FY24 revenue basis). It provides end-to-end solutions including design, manufacturing, assembly, installation, and commissioning of equipment with over 65+ unique designs and over 11,000 units delivered.